CA2084875A1 - Procedure for the purification of hyaluronic acid and fraction of pure hyaluronic acid for ophthalmic use - Google Patents

Procedure for the purification of hyaluronic acid and fraction of pure hyaluronic acid for ophthalmic use

Info

Publication number
CA2084875A1
CA2084875A1 CA2084875A CA2084875A CA2084875A1 CA 2084875 A1 CA2084875 A1 CA 2084875A1 CA 2084875 A CA2084875 A CA 2084875A CA 2084875 A CA2084875 A CA 2084875A CA 2084875 A1 CA2084875 A1 CA 2084875A1
Authority
CA
Canada
Prior art keywords
hyaluronic acid
fraction
purification
procedure
ophthalmic use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2084875A
Other languages
French (fr)
Other versions
CA2084875C (en
Inventor
Aurelio Romeo
Silvana Lorenzi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fidia SpA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11389548&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2084875(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of CA2084875A1 publication Critical patent/CA2084875A1/en
Application granted granted Critical
Publication of CA2084875C publication Critical patent/CA2084875C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Abstract

A highly pure fraction of hyaluronic acid is disclosed which is non-inflammatory and avoids post-operative complications in ocular surgery. Also disclosed is a process for the preparation of hyaluronic acid characterized by converting hyaluronic acid into a corresponding quaternary ammonium salt and, following purification procedures, reconverting the quaternary ammonium salt into a sodium salt of hyaluronic acid.
CA002084875A 1991-04-19 1992-04-16 Procedure for the purification of hyaluronic acid and fraction of pure hyaluronic acid for ophthalmic use Expired - Lifetime CA2084875C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITPD91A000077 1991-04-19
ITPD910077A IT1247175B (en) 1991-04-19 1991-04-19 PROCEDURE FOR PURIFICATION OF HYALURONIC ACID AND FRACTION OF PURE HYALURONIC ACID FOR OPHTHALMIC USE.

Publications (2)

Publication Number Publication Date
CA2084875A1 true CA2084875A1 (en) 1992-10-20
CA2084875C CA2084875C (en) 1998-01-06

Family

ID=11389548

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002084875A Expired - Lifetime CA2084875C (en) 1991-04-19 1992-04-16 Procedure for the purification of hyaluronic acid and fraction of pure hyaluronic acid for ophthalmic use

Country Status (24)

Country Link
US (1) US5559104A (en)
EP (1) EP0535200B1 (en)
JP (1) JP2580458B2 (en)
KR (1) KR0178544B1 (en)
AT (1) ATE186307T1 (en)
AU (1) AU653022B2 (en)
BR (1) BR9205240A (en)
CA (1) CA2084875C (en)
CZ (1) CZ282248B6 (en)
DE (1) DE69230242T2 (en)
DK (1) DK0535200T3 (en)
ES (1) ES2092971T3 (en)
FI (1) FI104973B (en)
GR (1) GR3032434T3 (en)
HU (1) HU215193B (en)
IL (2) IL101611A (en)
IT (1) IT1247175B (en)
NO (1) NO305520B1 (en)
PL (1) PL168477B1 (en)
RU (1) RU2128666C1 (en)
SG (1) SG46515A1 (en)
SK (1) SK280191B6 (en)
UA (1) UA27229C2 (en)
WO (1) WO1992018543A1 (en)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1274984B (en) * 1994-12-09 1997-07-29 Technopharma Sa SOLUTIONS VISCOSIZED WITH SODIUM HYALURONATE FOR USE AS A MASK FLUID IN THERAPEUTIC PHOTOCERATECTOMY BY ACCIMER LASER
IT1282219B1 (en) * 1995-12-20 1998-03-16 Fidia Advanced Biopolymers Srl COMBINED CHEMICAL-PHYSICAL PROCESS FOR THE PREPARATION OF LOW MOLECULAR WEIGHT HYALURONIC ACID FRACTIONS CHARACTERIZED BY LOW
IT1287967B1 (en) 1996-10-17 1998-09-10 Fidia Spa In Amministrazione S PHARMACEUTICAL PREPARATIONS FOR LOCAL ANESTHETIC USE
IT1291452B1 (en) 1997-04-14 1999-01-11 Fidia Advanced Biopolymers Srl COATING BASED ON HYALURONIC ACID AND ITS DERIVATIVES FOR THE PROTECTION OF ELECTRONIC PARTS FROM EXTERNAL AGENTS
US6958148B1 (en) 1998-01-20 2005-10-25 Pericor Science, Inc. Linkage of agents to body tissue using microparticles and transglutaminase
US6919076B1 (en) 1998-01-20 2005-07-19 Pericor Science, Inc. Conjugates of agents and transglutaminase substrate linking molecules
EP1091936B1 (en) 1998-05-29 2003-07-30 Bone Care International, Inc. Method for making hydroxy-25-ene-vitamin d compounds
DK172900B1 (en) 1998-12-18 1999-09-27 Per Julius Nielsen Preparation and kit for use in intraocular surgery
IT1306644B1 (en) 1999-04-08 2001-10-02 Fidia Advanced Biopolymers Srl THREE-DIMENSIONAL STRUCTURES INCLUDING HYALURONIC ACID DERIVATIVES OBTAINABLE THROUGH SUPERCRITICAL ANTI-SOLVENT TECHNIQUE.
KR100836733B1 (en) * 2002-11-15 2008-06-10 코오롱생명과학 주식회사 Method to withdrawal of sodium hyaluronate and therefor device
US20040167480A1 (en) * 2003-02-21 2004-08-26 Advanced Medical Optics, Inc. Administration of multiple viscoelastic solutions with a multi-compartment syringe
US20040180025A1 (en) * 2003-03-12 2004-09-16 New Life Resources, Llc Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
US20080063677A1 (en) * 2004-03-10 2008-03-13 New Life Resources, Llc Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
US6946551B2 (en) * 2003-03-12 2005-09-20 New Life Resources, Llc Preparation of hyaluronic acid from eggshell membrane
US8580315B2 (en) * 2004-03-10 2013-11-12 Esm Technologies, Llc Anti-inflammatory activity of eggshell membrane and processed eggshell membrane preparations
US20050266390A1 (en) * 2004-06-01 2005-12-01 Yuichiro Ueda Processes for removing cells and cell debris from tissue and tissue constructs used in transplantation and tissue reconstruction
KR100577075B1 (en) * 2004-06-16 2006-05-08 주식회사 티앤라이프시스템 Method for purifying hyaluronic acid using calcium salt and phosphate salt, or calcium phosphate salt
US7094775B2 (en) 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
US8021684B2 (en) * 2004-07-09 2011-09-20 Ferrosan Medical Devices A/S Haemostatic composition comprising hyaluronic acid
DE102005030011A1 (en) * 2005-06-17 2006-12-21 Aesculap Ag & Co. Kg Process for the preparation of sterile polysaccharide solutions
ITPD20050242A1 (en) 2005-08-03 2007-02-04 Fidia Farmaceutici BIOCONIUGATI ANTITUMORALI OF HYALURONIC ACID OR ITS DERIVATIVES, OBTAINABLE FOR DIRECT OR INDIRECT CHEMICAL CONJUGATION, AND THEIR USE IN PHARMACEUTICAL FIELD
ITMI20061668A1 (en) * 2006-09-01 2008-03-02 Schiena Michele Giuseppe Di COMPOSITION BASED ON HYALURONIC ACID AND ITS SALTS FOR THE TREATMENT OF EPITHELIAL INJURIES
KR101509139B1 (en) * 2006-11-23 2015-04-08 주식회사 엘지생명과학 Method for purifying hyaluronic acid
KR100894042B1 (en) * 2007-04-13 2009-04-20 가톨릭대학교 산학협력단 A method for preparing sulfasalazine hyaluronic acid compound and composition for after-cataract suppression containing compound prepared from the method
US9089592B2 (en) 2007-04-26 2015-07-28 Seikagaku Corporation Method for micro-incision cataract surgery, a method of evaluation of a viscoelastic material, a composition for evaluation of a viscoelastic material and a method for evaluation using the composition
US8759321B2 (en) * 2007-06-13 2014-06-24 Bausch & Lomb Incorporated Ophthalmic composition with hyaluronic acid and polymeric biguanide
KR20100094982A (en) * 2007-11-13 2010-08-27 바이오-테크널러지 제너럴 (이스라엘) 리미티드 Dilute filtration sterilization process for viscoelastic biopolymers
US8119112B2 (en) * 2008-01-31 2012-02-21 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and hyaluronic acid
US9096819B2 (en) 2008-01-31 2015-08-04 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and an anionic biopolymer
WO2009124266A2 (en) 2008-04-04 2009-10-08 University Of Utah Research Foundation Alkylated sem-synthetic glycosaminoglycosan ethers, and methods for making and using thereof
US20100286010A1 (en) * 2008-09-03 2010-11-11 Erning Xia Ophthalmic Compositions with Hyaluronic Acid
US20100086512A1 (en) 2008-10-02 2010-04-08 Rolf Schaefer Mucomimetic compositions and uses therefore
US20100178317A1 (en) * 2009-01-09 2010-07-15 Burke Susan E Lens Care Solutions with Hyaluronic Acid
WO2012118192A1 (en) * 2011-03-02 2012-09-07 電気化学工業株式会社 Aqueous solution containing hyaluronic acid or salt thereof
KR20140024862A (en) * 2011-03-02 2014-03-03 덴키 가가쿠 고교 가부시기가이샤 Aqueous solution containing hyaluronic acid or salt thereof
CN103547273A (en) * 2011-03-02 2014-01-29 电气化学工业株式会社 Pre-filled syringe filling syringe having resin barrel with aqueous solution containing hyaluronic acid or salt thereof
WO2012118193A1 (en) * 2011-03-02 2012-09-07 電気化学工業株式会社 Aqueous solution containing hyaluronic acid or salt thereof
KR20140024863A (en) * 2011-03-02 2014-03-03 덴키 가가쿠 고교 가부시기가이샤 Aqueous solution containing hyaluronic acid or salt thereof
EP2688402B1 (en) 2011-03-23 2018-10-24 University of Utah Research Foundation Means for treating or preventing urological inflammation
RU2477138C1 (en) * 2011-11-02 2013-03-10 Общество с ограниченной ответственностью Научно-производственное предприятие "Тульская индустрия ЛТД" Method for preparing filling material for plastic surgery and instrumental cosmetology, filling material and method for introducing filling material into problem area
ITMI20120664A1 (en) 2012-04-20 2013-10-21 Anika Therapeutics Srl GELLANE BASED BIOMATERIALS FOR USE AS FILLER IN SURGERY
US10723812B2 (en) 2014-02-06 2020-07-28 New York University Method for separating hyaluronan and quantifying its molecular mass distribution in biological samples
IT201600079633A1 (en) * 2016-07-28 2018-01-28 Fidia Farm Spa Preparation and purification process of the sodium salt of hyaluronic acid
WO2018053111A1 (en) 2016-09-15 2018-03-22 University Of Utah Research Foundation In situ gelling compositions for the treatment or prevention of inflammation and tissue damage
AU2020395914A1 (en) 2019-12-05 2022-05-19 Cis Pharma Ag High hyaluronate multi-purpose disinfection solutions for ophthalmic applications
RU2765951C1 (en) * 2021-05-14 2022-02-07 Общество с ограниченной ответственностью "АВЕО" Method of purifying hyaluronate from endotoxins

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT252264B (en) * 1965-03-17 1967-02-10 Etapharm Chem Pharm Lab Ges M Process for the production of a pure, highly viscous hyaluronic acid preparation
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US4766348A (en) * 1983-06-09 1988-08-23 Gte Products Corporation Single-ended metal halogen lamp and fabrication process employing ionization potential selection of additive gases
LU85582A1 (en) * 1983-10-11 1985-06-04 Fidia Spa HYALURONIC ACID FRACTIONS HAVING PHARMACEUTICAL ACTIVITY, METHODS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
NO161573C (en) * 1983-11-25 1989-08-30 Miles Inc PROCEDURE FOR THE PREPARATION OF HYALURONIC ACID.
US5093487A (en) * 1986-01-06 1992-03-03 Mobay Corporation Low viscosity high molecular weight filter sterilizable hyaluronic acid
JPS6121241A (en) * 1984-07-10 1986-01-29 オリエンタル建設株式会社 Construction of multi-spun beam in prestressed concrete member assembling type lamen structure
US4784990A (en) * 1985-01-18 1988-11-15 Bio-Technology General Corporation High molecular weight sodium hyaluronate
AU600257B2 (en) * 1986-03-21 1990-08-09 International Pharmaceutical Products, Inc. Non-inflammatory hyaluronic acid fraction and process for preparing it
IT1198449B (en) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani ESTERS OF POLYVALENT ALCOHOLS OF HYALURONIC ACID
JPH0813847B2 (en) * 1987-08-11 1996-02-14 日本化薬株式会社 Fractionation method of hyaluronic acid
JPH01210401A (en) * 1988-02-17 1989-08-24 Mitsubishi Rayon Co Ltd Separation of acidic polysaccharide
JPH0723317B2 (en) * 1988-03-17 1995-03-15 生化学工業株式会社 Corneal epithelial disorder treatment
US4920104A (en) * 1988-05-16 1990-04-24 Medchem Products, Inc. Sodium hyaluronate composition
JP2731545B2 (en) * 1988-10-12 1998-03-25 電気化学工業株式会社 Method for purifying hyaluronic acid

Also Published As

Publication number Publication date
ES2092971T1 (en) 1996-12-16
SK280191B6 (en) 1999-09-10
DE69230242T2 (en) 2000-06-21
IT1247175B (en) 1994-12-12
DE69230242D1 (en) 1999-12-09
FI925756A0 (en) 1992-12-18
AU1576692A (en) 1992-11-17
IL113453A (en) 1995-07-31
HU215193B (en) 1998-10-28
EP0535200A1 (en) 1993-04-07
ITPD910077A1 (en) 1992-10-19
HU9204012D0 (en) 1993-03-29
FI925756A (en) 1992-12-18
ES2092971T3 (en) 2000-01-01
CA2084875C (en) 1998-01-06
KR930700557A (en) 1993-03-15
IL113453A0 (en) 1995-07-31
NO924873D0 (en) 1992-12-16
FI104973B (en) 2000-05-15
AU653022B2 (en) 1994-09-15
HUT63186A (en) 1993-07-28
JP2580458B2 (en) 1997-02-12
WO1992018543A1 (en) 1992-10-29
PL297297A1 (en) 1993-09-06
NO924873L (en) 1993-02-19
CZ282248B6 (en) 1997-06-11
ITPD910077A0 (en) 1991-04-19
EP0535200B1 (en) 1999-11-03
RU2128666C1 (en) 1999-04-10
PL168477B1 (en) 1996-02-29
US5559104A (en) 1996-09-24
KR0178544B1 (en) 1999-04-01
NO305520B1 (en) 1999-06-14
ATE186307T1 (en) 1999-11-15
DK0535200T3 (en) 2000-05-08
SK377192A3 (en) 1995-06-07
BR9205240A (en) 1993-08-31
UA27229C2 (en) 2000-08-15
CZ377192A3 (en) 1993-05-12
GR3032434T3 (en) 2000-05-31
JPH05508183A (en) 1993-11-18
SG46515A1 (en) 1998-02-20
IL101611A (en) 1996-06-18

Similar Documents

Publication Publication Date Title
CA2084875A1 (en) Procedure for the purification of hyaluronic acid and fraction of pure hyaluronic acid for ophthalmic use
RU92016520A (en) HYALURONIC ACID FRACTION OR ITS SALT FOR APPLICATION IN OPHTHALMOLOGY, METHOD FOR OBTAINING HYALURONIC ACID AND ITS SALT, PHARMACEUTICAL PREPARATION
CA2213339A1 (en) Method of treating adenosine depletion
CA2129287A1 (en) Use of cloprostenol, fluprostenol and their analogues to treat glaucoma and ocular hypertension
IE56177B1 (en) Celiprolol for the treatment of glaucoma
AU1331588A (en) Method for treatment of alcohol abuse
CA2154103A1 (en) Treatment of Mucous Membrane Disease, Trauma or Condition and for the Relief of Pain
EP0287193A3 (en) Use of nedocromil sodium in the treatment of cystic fibrosis
CA2029657A1 (en) Compositions and their use in lowering intraocular pressure
AU3327489A (en) Ophthalmic solution for intraocular pressure adjustment
CA2165329A1 (en) Process for the preparation of n-acetyl neuraminic acid derivatives
AU2829395A (en) Method for reducing intraocular pressure in the mammalian eye by administration of calcium chelators
AU6290296A (en) Preparation of bicyclohexane derivative
CA2120319A1 (en) Pharmaceutical for the treatment of skin disorders
AU5600890A (en) Dibenzo (1,5) dioxocin-5-one derivatives, their use in medicaments and processes for their preparation
EP0345028A3 (en) Treatment of glaucoma using phosphodiesterase inhibitor
CA2167926A1 (en) Use of benzydamine in the treatment of pathological conditions caused by tnf
CA2190952A1 (en) Use of a naphthalenesulfonic acid compound for inhibiting retroviral infection
CA2101548A1 (en) Acylamino-alkylidenhydroxy-bisphosphonic acids useful in the therapy of osteoarticular diseases
AU5932394A (en) New compound, leustroducsin H, its preparation and its therapeutic use
CA2561293A1 (en) Treatment of incontinence
EP0634436A4 (en) Sulfate of n-acetylneuraminic acid homopolymer, process for producing the same, anti-hiv drug containing said sulfate, method of treating aids with said sulfate, use of said sulfate for treating aids, and use of said sulfate for producing the drug.
AU625096C (en) Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
AU6295094A (en) Compositions for the treatment of eye diseases
IT1238697B (en) A pharmaceutical composition a type of eye drops that act as an anti-inflammatory and the process used to prepare it.

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry
MKEX Expiry

Effective date: 20120416